Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Lipoprotein Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00092625
What this trial is testing

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 442
Early research (Phase 1)Looking for participantsNCT06980428
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

Who this might be right for
Healthy ParticipantsDyslipidemia
AstraZeneca 136
Early research (Phase 1)Study completedNCT01554800
What this trial is testing

Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseAtherosclerosis
MedImmune LLC 16
Testing effectiveness (Phase 2)Ended earlyNCT03960541
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003)

Who this might be right for
HIV InfectionsDyslipidemias
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 8
Testing effectiveness (Phase 2)Study completedNCT02633956
What this trial is testing

Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

Who this might be right for
Nonalcoholic Steatohepatitis
Intercept Pharmaceuticals 84
Early research (Phase 1)Study completedNCT00055042
What this trial is testing

Laser and Antioxidant Treatment of Diabetic Macular Edema

Who this might be right for
Macular EdemaDiabetes Mellitus
National Eye Institute (NEI) 40
Testing effectiveness (Phase 2)Study completedNCT00268996
What this trial is testing

Integrated Biomarker And Imaging Study - 2

Who this might be right for
Atherosclerosis
GlaxoSmithKline 336
Not applicableStudy completedNCT02258932
What this trial is testing

CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal Study

Who this might be right for
Type 1 Diabetes
Liverpool John Moores University 5
Post-approval studies (Phase 4)Study completedNCT02153879
What this trial is testing

Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment

Who this might be right for
Type 2 Diabetes MellitusDyslipidemia
Institut Investigacio Sanitaria Pere Virgili 30
Not applicableUnknownNCT05422092
What this trial is testing

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Early research (Phase 1)Study completedNCT00990808
What this trial is testing

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 46
Testing effectiveness (Phase 2)Study completedNCT06816264
What this trial is testing

HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Treatment of Lipoprotein Disorder
Shandong Suncadia Medicine Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT01953328
What this trial is testing

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Who this might be right for
Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
Amgen 409
Not applicableStudy completedNCT03791216
What this trial is testing

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

Who this might be right for
Psoriasis
Northwestern University 62
Testing effectiveness (Phase 2)Study completedNCT01375777
What this trial is testing

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Who this might be right for
Hyperlipidemia
Amgen 411
Post-approval studies (Phase 4)UnknownNCT00433823
What this trial is testing

A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

Who this might be right for
Coronary Heart DiseaseDiabetes MellitusNon-Coronary Atherosclerotic Disease+1 more
Abant Izzet Baysal University
Not applicableWithdrawnNCT00572429
What this trial is testing

Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART

Who this might be right for
HIV InfectionsHyperlipidemiaExercise
University of California, Davis
Post-approval studies (Phase 4)UnknownNCT02593487
What this trial is testing

Effect of Rosuvastatin Therapy on HDL2 Level

Who this might be right for
HyperlipemiaCoronary Heart Disease
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590012
What this trial is testing

SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY

Who this might be right for
AtherosclerosisAtheroscleroses, CoronaryCarotid Atherosclerosis
Institute for Atherosclerosis Research, Russia 1,228
Not applicableLooking for participantsNCT07359105
What this trial is testing

Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

Who this might be right for
Dyslipidemia Associated With Type II Diabetes Mellitus
Sin Gon Kim 2,186
Next Page